Search Results - "OLLIARO, P"

Refine Results
  1. 1

    Leishmaniasis chemotherapy—challenges and opportunities by Croft, S.L., Olliaro, P.

    Published in Clinical microbiology and infection (01-10-2011)
    “…Although there have been significant advances in the treatment of visceral leishmaniasis (VL), there remain challenges to ensure that treatments effective in…”
    Get full text
    Journal Article
  2. 2

    The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer) by Olliaro, Piero, Delgado-Romero, Petra, Keiser, Jennifer

    Published in Journal of antimicrobial chemotherapy (01-04-2014)
    “…Praziquantel has been the mainstay of schistosomiasis control since 1984 and widely distributed since 2006 through ‘preventive chemotherapy’ programmes to…”
    Get full text
    Journal Article
  3. 3

    The Global Portfolio of New Antimalarial Medicines Under Development by Olliaro, P, Wells, TNC

    Published in Clinical pharmacology and therapeutics (01-06-2009)
    “…With the elimination of malaria now considered a realistic goal, it would be useful for scientists and policy makers to have an inventory of the arsenal of…”
    Get full text
    Journal Article
  4. 4

    Mode of action and mechanisms of resistance for antimalarial drugs by Olliaro, P

    Published in Pharmacology & therapeutics (Oxford) (01-02-2001)
    “…Understanding the mode of action of and mechanism of resistance to drugs is central to optimising their use, and discovering new therapeutics with novel…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma by Hodel, E.M., Zanolari, B., Mercier, T., Biollaz, J., Keiser, J., Olliaro, P., Genton, B., Decosterd, L.A.

    “…Among the various determinants of treatment response, the achievement of sufficient blood levels is essential for curing malaria. For helping us at improving…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India by Olliaro, P, Sundar, S

    “…To estimate drug costs of treating visceral leishmaniasis (VL) based on data on the VL population structure from the high-burden, antimony-resistant area of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review by Danso-Appiah, A, Garner, P, Olliaro, P L, Utzinger, J

    Published in Parasitology (01-11-2009)
    “…Guidelines recommend praziquantel (PZQ) for the treatment and control of schistosomiasis, with no real alternative. Metrifonate was still widely used against…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review by Olliaro PL, Taylor WRJ

    Published in Journal of postgraduate medicine (Bombay) (01-01-2004)
    “…The emergence and spread of drug resistant malaria represents a considerable challenge to controlling malaria. To date, malaria control has relied heavily on a…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Hypoxia modulates the effect of dihydroartemisinin on endothelial cells by D’Alessandro, S., Basilico, N., Corbett, Y., Scaccabarozzi, D., Omodeo-Salè, F., Saresella, M., Marventano, I., Vaillant, M., Olliaro, P., Taramelli, D.

    Published in Biochemical pharmacology (01-09-2011)
    “…Artemisinin derivatives, the current cornerstone of malaria treatment, possess also anti-angiogenic and anti-tumor activity. Hypoxia plays a crucial role both…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Averting a malaria disaster by White, NJ, Nosten, F, Looareesuwan, S, Watkins, WM, Marsh, K, Snow, RW, Kokwaro, G, Ouma, J, Hien, TT, Molyneux, ME, Taylor, TE, Newbold, CI, Ruebush, TK, Danis, M, Greenwood, BM, Anderson, RM, Olliaro, P

    Published in The Lancet (British edition) (05-06-1999)
    “…As treatments loose their effectiveness, morbidity and mortality from malaria will inevitably continue to rise. The rationale for combining drugs with…”
    Get full text
    Journal Article
  20. 20

    Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria by Zaloumis, S G, Tarning, J, Krishna, S, Price, R N, White, N J, Davis, T M E, McCaw, J M, Olliaro, P, Maude, R J, Kremsner, P, Dondorp, A, Gomes, M, Barnes, K, Simpson, J A

    “…There are ~660,000 deaths from severe malaria each year. Intravenous artesunate (i.v. ARS) is the first‐line treatment in adults and children. To optimize the…”
    Get full text
    Journal Article